“Hematological Adverse Effects in HCV Patients Treated With Pegylated Interferon and Ribavirin in a Tertiary Care Hospital Peshawar”. Medical Forum Monthly 26, no. 3 (May 2, 2024). Accessed February 1, 2026. https://medicalforummonthly.com/index.php/mfm/article/view/2736.